BioGaia develops, markets and sells probiotic products. Probiotics are useful bacteria that have documented positive health effects in the body. The applications for BioGaia products are mainly in gastrointestinal, oral and immune health and the products are available in a variety of different types of bottles. Sales are mainly through distribution partners in pharmacies worldwide. The company has two business areas: Pediatrics and Adult Health.
We note a number of risks factors for BioGaia, including market risk, partnership risk, competition, legal and regulatory risk, product development risk and currency and macroeconomic risk. From a short-term perspective there is a risk of destocking effect in some markets.